Commercialization and searching for a business model: why is spinning technology out of a lab so challenging?
In this talk, we will explore the four critical challenges of getting technology out of a lab. Dr. Arkilic, Chief Innovation Officer of UCI has spent his entire career in supporting getting technology out of Academic labs. He has been founder StrataGent Life Sciences, Inc., lead program manager for the NSF SBIR program, founder of the NSF I-Corps program and founder of M34 Capital, a venture capital firm in Silicon Valley.
Errol Arkilic is Chief Innovation Officer and Executive Director of University of California, Irvine Beall Applied Innovation. At UCI, he leads campus‐wide commercialization activity, helping researchers turn knowledge into products and services that impact society. Prior to his role at UCI, he was founder and CEO of M34 Capital. M34 is a private investment company that focuses on seed and early‐stage projects being spun out of academic research labs. He currently sits on three boards: Growcentia, Inc. NeuroTrainer, Inc. and Ellis Day Skin Science, Inc. Previously, Errol was the founding and lead program director for the National Science Foundation Innovation Corps program (I‐Corps). He led the I‐Corps effort from its inception until July 2013. Prior to this, he was the lead software and services Program Director for the NSF SBIR program. Before his government service, Errol was founder and CEO of StrataGent Life Sciences (Acquired by Corium International: CORI) and Manager of Product Engineering at Redwood Microsystems. He has a Ph.D. in Aero/Astro Engineering from MIT.